Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: Development and evaluation

AAPS PharmSciTech

Volumn 14, Issue 3, 2013, Pages 1012-1024

  Youngren, Susanne R ^a   Mulik, Rohit ^a   Jun, Byoung ^a   Hoffmann, Peter R ^b   Morris, Kenneth R ^a   Chougule, Mahavir B ^a  

^a UNIVERSITY OF HAWAII AT HILO   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

mannosylation; nanoliposome; selenium; thermal properties

Indexed keywords

LIPOSOME; MANNOSAMINE; NANOLIPOSOME; SELENIUM; SODIUM SELENITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; FREEZE DRYING; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; THERMAL ANALYSIS; X RAY DIFFRACTION; ZETA POTENTIAL;

ANIMALS; CELLS, CULTURED; FREEZE DRYING; LIPOSOMES; MANNOSE; MICE; NANOSTRUCTURES; POWDER DIFFRACTION; SELENIUM; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84890248054     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-013-9988-3     Document Type: Article

References (105)

1. Navarro-Alarcon M, Lopez-Martinez MC. Essentiality of selenium in the human body: relationship with different diseases. Sci Total Environ. 2000;249(1-3):347-71. PubMed PMID: 10813463. Epub 2000/05/17. eng.
2. Huang Z, Rose AH, Hoffmann PR. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2012;16(7):705-43. PubMed PMID: 21955027. Pubmed Central PMCID: PMC3277928. Epub 2011/10/01. eng.
3. Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE, et al. Selenium in human health and disease. Antioxid Redox Signal. 2011;14(7):1337-83. PubMed PMID: 20812787. Epub 2010/09/04. eng.
4. Brinkman M, Buntinx F, Muls E, Zeegers MP. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol. 2006;7:766-74.
5. Stone R. A medical mystery in middle China. Science. 2009;324(5933):1378- 81. PubMed PMID: WOS:000266878700008.
6. Flatt A, Pearce N, Thomson CD, Sears MR, Robinson MF, Beasley R. Reduced selenium in asthmatic subjects in New Zealand. Thorax. 1990;45(2):95-9. PubMed PMID: 2315881. Pubmed Central PMCID: PMC462313. Epub 1990/02/01. eng.
7. Hasselmark L, Malmgren R, Unge G, Zetterstrom O. Lowered platelet glutathione-peroxidase activity in patients with intrinsic asthma. Allergy. 1990;45(7):523-7. PubMed PMID: WOS:A1990EC54200006.
8. Kocyigit A, Armutcu F, Gurel A, Ermis B. Alterations in plasma essential trace elements selenium, manganese, zinc, copper, and iron concentrations and the possible role of these elements on oxidative status in patients with childhood asthma. Biol Trace Elem Res. 2004;97(1):31-41. PubMed PMID: WOS:000188192800003.
9. de Luis DA, Izaola O, Aller R, Armentia A, Cuellar L. Antioxidant and fat intake in patients with polinic asthma. Medicina Clinica. 2003;121(17):653-4. PubMed PMID: WOS:000187618300004.
10. Qujeq D, Hidari B, Bijani K, Shirdel H. Glutathione peroxidase activity and serum selenium concentration in intrinsic asthmatic patients. Clin Chem Lab Med. 2003;41(2):200-2. PubMed PMID: WOS:000181095800014.
11. Omland O, Deguchi Y, Sigsgaard T, Hansen JC. Selenium serum and urine is associated to mild asthma and atopy. The SUS study. J Trace Elem Med Biol. 2002;16(2):123-7. PubMed PMID: WOS:000177406700009.
12. Misso NLA, Powers KA, Gillon RL, Stewart GA, Thompson PJ. Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients. Clin Exp Allergy. 1996;26(7):838-47. PubMed PMID: WOS:A1996UY84300015.
13. Kadrabova J, Madaric A, Kovacikova Z, Podivinsky F, Ginter E, Gazdik F. Selenium status is decreased in patients with intrinsic asthma. Biol Trace Elem Res. 1996;52(3):241-8. PubMed PMID: WOS:A1996UV44000003.
14. Shaw R, Woodman K, Crane J, Moyes C, Kennedy J, Pearce N. Risk-factors for asthma symptoms in Kawerau children. New Zeal Med J. 1994;107(987):387-91. PubMed PMID: WOS:A1994PN14500001.
15. McKenzie RC, Rafferty TS, Beckett GJ. Selenium: an essential element for immune function. Immunol Today. 1998;19(8):342-5. PubMed PMID: WOS:000075213400002.
16. Ford ES, Mannino DM, Redd SC. Serum antioxidant concentrations among US adults with self-reported asthma. J Asthma. 2004;41(2):179-87. PubMed PMID: WOS:000220964200006.
17. Thomson CD, Wickens K, Miller J, Ingham T, Lampshire P, Epton MJ, et al. Selenium status and allergic disease in a cohort of New Zealand children. Clin Exp Allergy. 2012;42(4):560-7. PubMed PMID: 22417214. Epub 2012/03/16. eng.
18. Patelarou E, Giourgouli G, Lykeridou A, Vrioni E, Fotos N, Siamaga E, et al. Association between biomarker-quantified antioxidant status during pregnancy and infancy and allergic disease during early childhood: a systematic review. Nutr Rev. 2011;69(11):627-41. PubMed PMID: 22029830. Epub 2011/10/28. eng.
19. van Oeffelen AAM, Bekkers MBM, Smit HA, Kerkhof M, Koppelman GH, Haveman-Nies A, et al. Serum micronutrient concentrations and childhood asthma: the PIAMA birth cohort study. Pediatr Allergy Immunol. 2011;22(8):784-93. PubMed PMID: WOS:000298095300005.
20. Nurmatov U, Devereux G, Sheikh A. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis. J Allergy Clin Immunol. United States: Asthma & Immunology. Published by Mosby; 2011;127:724-33 e1-30.
21. Bakkeheim E, Mowinckel P, Carlsen KH, Burney P, Carlsen KC. Altered oxidative state in schoolchildren with asthma and allergic rhinitis. Pediatr Allergy Immunol. 22. England: 2010 Wiley. 2011. 178-85.
22. Hoffmann PR, Saux CJL, Hoffmann FW, Chang PS, Bollt O, He QP, et al. A role for dietary selenium and selenoproteins in allergic airway inflammation. J Immunol. 2007;179(5):3258-67. PubMed PMID: WOS:000248991800068.
23. Hoffmann FW, Hashimoto AC, Shafer LA, Dow S, Berry MJ, Hoffmann PR. Dietary selenium modulates activation and differentiation of CD4(+) T cells in mice through a mechanism involving cellular free thiols. J Nutr. 2010;140(6):1155-61. PubMed PMID: WOS:000277800700015.
24. Jeong DW, Yoo MH, Kim TS, Kim JH, Kim IY. Protection of mice from allergen-induced asthma by selenite - prevention of eosinophil infiltration by inhibition of NF-kappa B activation. J Biol Chem. 2002;277(20):17871-6. PubMed PMID: WOS:000175685100062. English.
25. May SW. Selenium-based drug design: rationale and therapeutic potential. Expert Opin Investig Drugs. 1999;8(7):1017-30. PubMed PMID: 15992103. Epub 2005/07/05. eng.
26. Venardos KM, Perkins A, Headrick J, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem. 2007;14(14):1539-49. PubMed PMID: 17584062. Epub 2007/06/23. eng.
27. Ferguson LR, Karunasinghe N. Nutrigenetics, nutrigenomics, and selenium. Front Genet. 2011;2:15. PubMed PMID: 22303312. Pubmed Central PMCID: PMC3268570. Epub 2012/02/04. eng.
28. Dunn BK, Richmond ES, Minasian LM, Ryan AM, Ford LG. A nutrient approach to prostate cancer prevention: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Nutr Canc Intl J. 2010;62(7):896-918. PubMed PMID: WOS:000282583200007.
29. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147:217-23.
30. Wang D, Taylor EW, Wang Y, Wan X, Zhang J. Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention. Int J Nanomed. 2012;7:1711-21.
31. Zhang JS, Gao XY, Zhang LD, Bao YP. Biological effects of a nano red elemental selenium. Biofactors. 2001;15(1):27-38. PubMed PMID: 11673642. Epub 2001/10/24. eng.
32. Caliph SM, Charman WN, Porter CJH. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci. 2000;89(8):1073-84. PubMed PMID: WOS:000088733500012.
33. Clark MA, Jepson MA, Hirst BH. Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev. 2001;50(1-2):81-106. PubMed PMID: WOS:000171145500006.
34. Porter CJH, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 2001;50(1-2):61-80. PubMed PMID: WOS:000171145500005.
35. Salman HH, Irache JM, Gamazo C. Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination. Vaccine. 2009;27(35):4784-90. PubMed PMID: WOS:000268827500010.
36. Salman HH, Gamazo C, Campanero MA, Irache JM. Bioadhesive mannosylated nanoparticles for oral drug delivery. J Nanosci Nanotechnol. 2006;6(9-10):3203-9. PubMed PMID: WOS:000240865900070.
37. Kaur CD, Nahar M, Jain NK. Lymphatic targeting of zidovudine using surface-engineered liposomes. J Drug Target. 2008;16(10):798-805. PubMed PMID: WOS:000260851900008.
38. Lian T, Ho RJ. Trends and developments in liposome drug delivery systems. J Pharm Sci. 90. United States: 2001 Wiley-Liss; 2001. p. 667-80.
39. Szelenyi I. Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases. Inflamm Res. 2012;61(1):1-9. PubMed PMID: 22057873. Epub 2011/11/08. eng.
40. Vunta H, Belda BJ, Arner RJ, Channa Reddy C, Vanden Heuvel JP, Sandeep Prabhu K. Selenium attenuates pro-inflammatory gene expression in macrophages. Mol Nutr Food Res. 2008;52(11):1316-23. PubMed PMID: 18481333. Epub 2008/05/16. eng.
41. Chougule M, Padhi B, Misra A. Development of spray dried liposomal dry powder inhaler of Dapsone. AAPS PharmSciTech. 2008;9(1):47-53. PubMed PMID: 18446460. Pubmed Central PMCID: PMC2976880. Epub 2008/05/01. eng.
42. Chu C, Tong SS, Xu Y, Wang L, Fu M, Ge YR, et al. Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo. Acta Pharmacol Sin. 2011;32:973-80. United States.
43. Lu T, Ma Y, Hu H, Chen Y, Zhao W, Chen T. Ethinylestradiol liposome preparation and its effects on ovariectomized rats' osteoporosis. Drug Deliv. 2011;18(7):468-77. PubMed PMID: 21688973. Epub 2011/06/22. eng.
44. Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71(4):349-58. PubMed PMID: 20502539. Pubmed Central PMCID: PMC2865805. Epub 2010/05/27. eng.
45. Roth M. Fluorescence reaction for amino acids. Anal Chem. 1971;43(7):880-2. PubMed PMID: 5576608. Epub 1971/06/01. eng.
46. Dominguez LM, Dunn RS. Analysis of OPA-derivatized amino sugars in tobacco by high-performance liquid chromatography with fluorimetric detection. J Chromatogr Sci. 1987;25(10):468-71. PubMed PMID: 3667835. Epub 1987/10/01. eng.
47. Chen SY, Collipp PJ, Boasi LH, Isenschmid DS, Verolla RJ, Sanroman GA, et al. Fluorometry of selenium in human-hair, urine and blood - a single-tube process for sub-microgram determination of selenium. Ann Nutr Metab. 1982;26(3):186-90. PubMed PMID: WOS:A1982NX76600006. English.
48. Allaway WH, Cary EE. Determination of submicrogram amounts of selenium in biological materials. Anal Chem. 1964;36(7):1359-62.
49. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of Childhood Asthma in the United States, 1980-2007. Pediatrics. 2009 Mar;123:S131-S45. PubMed PMID: WOS:000263826000002.
50. Carneiro MFH, Rhoden CR, Amantea SL, Barbosa F. Low concentrations of selenium and zinc in nails are associated with childhood asthma. Biol Trace Elem Res. 2011;144(1-3):244-52. PubMed PMID: WOS:000298192900024.
51. Guo CH, Liu PJ, Hsia S, Chuang CJ, Chen PC. Role of certain trace minerals in oxidative stress, inflammation, CD4/CD8 lymphocyte ratios and lung function in asthmatic patients. Ann Clin Biochem. 2011;48:344-51. England.
52. Yan L, Johnson LK. Selenium bioavailability from naturally produced high-selenium peas and oats in selenium-deficient rats. J Agric Food Chem. 2011;59(11):6305-11. PubMed PMID: 21553810. Epub 2011/05/11. eng.
53. Hambidge KM. Micronutrient bioavailability: dietary reference intakes and a future perspective. Am J Clin Nutr. 2010;91:1430S-2S. United States.
54. Cases J, Wysocka IA, Caporiccio B, Jouy N, Besancon P, Szpunar J, et al. Assessment of selenium bioavailability from high-selenium spirulina subfractions in selenium-deficient rats. J Agric Food Chem. 2002;50(13):3867-73. PubMed PMID: WOS:000176267800039.
55. Plano D, Baquedano Y, Ibanez E, Jimenez I, Palop JA, Spallholz JE, et al. Antioxidant-prooxidant properties of a new organoselenium compound library. Molecules. 2010;15:7292-312. Switzerland.
56. von Rosen L, Podjaski B, Bettmann I, Otto HF. Observations on the ultrastructure and function of the so-called "microfold" or "membraneous" cells (M cells) by means of peroxidase as a tracer. Virchows Arch A Pathol Anat Histol. 1981;390(3):289-312. PubMed PMID: 7281480. Epub 1981/01/01. eng.
57. Fujimura Y. Functional morphology of microfold cells (M cells) in Peyer's patches - phagocytosis and transport of BCG by M cells into rabbit Peyer's patches. Gastroenterol Jpn. 1986;21(4):325-35. PubMed PMID: 3770353. Epub 1986/08/01. eng.
58. Gupta PN, Vyas SP. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization. Colloids Surf B Biointerfaces. 82. Netherlands: 2010 Elsevier B.V; 2011. p. 118-25.
59. Hsieh EH, Lo DD. Jagged1 and Notch1 help edit M cell patterning in Peyer's patch follicle epithelium. Dev Comp Immunol. 37. United States: 2012 Elsevier Ltd; 2012. p. 306-12.
60. Jepson MA, Simmons NL, Savidge TC, James PS, Hirst BH. Selective binding and transcytosis of latex microspheres by rabbit intestinal M-cells. Cell Tissue Res. 1993;271(3):399-405. PubMed PMID: WOS:A1993KR83100002.
61. Clark MA, Blair H, Liang L, Brey RN, Brayden D, Hirst BH. Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccine. 2001;20(1-2):208-17. PubMed PMID: WOS:000171512000031. English.
62. Pukanud P, Peungvicha P, Sarisuta N. Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer's patches. Drug Deliv. 2009;16(5):289-94. PubMed PMID: WOS:000268575100009. English.
63. Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed. 2006;1(3):297-315. PubMed PMID: 17717971. Pubmed Central PMCID: PMC2426795. Epub 2007/08/28. eng.
64. Shoji Y, Nakashima H. Nutraceutics and delivery systems. J Drug Target. 2004;12:385-91. England.
65. Gomez-Hens A, Fernandez-Romero JM. Analytical methods for the control of liposomal delivery systems. Trac-Trends Anal Chem. 2006;25(2):167-78. PubMed PMID: WOS:000235414500015.
66. Mozafari MR, Johnson C, Hatziantoniou S, Demetzos C. Nanoliposomes and their applications in food nanotechnology. J Liposome Res. 2008;18:309-27. United States.
67. Mozafari MR. Nanoliposomes: preparation and analysis. Meth Mol Biol. 2010;605:29-50. PubMed PMID: 20072871. Epub 2010/01/15. eng.
68. Mozafari MRM, Mortazavi SM. Nanoliposomes: from fundamentals to recent developments. Oxford, UK: Trafford; 2005.
69. Hauser H. Mechanism of spontaneous vesiculation. Proc Natl Acad Sci U S A. 1989;86(14):5351-5. Pubmed Central PMCID: PMC297620. Epub 1989/07/01. eng.
70. Mura P, Maestrelli F, Gonzalez-Rodriguez ML, Michelacci I, Ghelardini C, Rabasco AM. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm. 2007;67:86-95. Netherlands.
71. Colas JC, Shi W, Rao VS, Omri A, Mozafari MR, Singh H. Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting. Micron. 2007;38:841-7. England.
72. Girod de Bentzmann S, Pierrot D, Fuchey C, Zahm JM, Morancais JL, Puchelle E. Distearoyl phosphatidylglycerol liposomes improve surface and transport properties of CF mucus. Eur Respir J. 1993;6(8):1156-61. PubMed PMID: 8224130. Epub 1993/09/01. eng.
73. Metselaar JM, Bruin P, de Boer LW, de Vringer T, Snel C, Oussoren C, et al. A novel family of l-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity. Bioconjugate Chem. 2003;14(6):1156-64. PubMed PMID: 14624629. Epub 2003/11/20. eng.
74. Deniz A, Sade A, Severcan F, Keskin D, Tezcaner A, Banerjee S. Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics. Biosci Rep. 2010;30:365-73. United States.
75. Berg J, Tymoczko JL, Stryer L. Section 12.3, There are three common types of membrane lipids. Biochemistry. 2002.
76. Wu Y, Ho YP, Mao Y, Wang X, Yu B, Leong KW, et al. Uptake and intracellular fate of multifunctional nanoparticles: a comparison between lipoplexes and polyplexes via quantum dot mediated Forster resonance energy transfer. Mol Pharm. 2011;8(5):1662-8. PubMed PMID: 21740056. Pubmed Central PMCID: PMC3185110. Epub 2011/07/12. eng.
77. Elder A, Vidyasagar S, DeLouise L. Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(4):434-50. PubMed PMID: 20049809. Epub 2010/01/06. eng.
78. Ponchel G, Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev. 1998;34:191-219.
79. Toy R, Hayden E, Shoup C, Baskaran H, Karathanasis E. The effects of particle size, density and shape on margination of nanoparticles in microcirculation. Nanotechnology. 2011;22(11):115101. PubMed PMID: 21387846. Epub 2011/03/11. eng.
80. Paliwal R, Paliwal SR, Mishra N, Mehta A, Vyas SP. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. Int J Pharm. 2009;380(1-2):181-8. PubMed PMID: WOS:000270495400025.
81. Allen TM, Hansen C. Pharmacokinetics of stealth versus conventional liposomes - effect of dose. Biochimica Et Biophysica Acta. 1991;1068(2):133-41. PubMed PMID: WOS:A1991GL84200003.
82. Nicholas TE, Barr HA, Power JH, Jones ME. Uptake of instilled radiolabeled lamellar bodies from alveolar compartment of the rat. Am J Physiol. 1990;259(4 Pt 1):L238-46. PubMed PMID: 2221085. Epub 1990/10/01. eng.
83. Tagami T, May JP, Ernsting MJ, Li SD. A thermosensitive liposome prepared with a Cu2+ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy. J Contr Release. 2012;161(1):142-9. PubMed PMID: WOS:000305790100016.
84. Ganta S, Deshpande D, Korde A, Amiji M. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers. Mol Membr Biol. 2010;27(7):260-73. PubMed PMID: 20929336. Epub 2010/10/12. eng.
85. Gerasimov OV, Boomer JA, Qualls MM, Thompson DH. Cytosolic drug delivery using pH- and light-sensitive liposomes. Adv Drug Deliv Rev. 1999;38:317-38.
86. Lentz BR, Lee JK. Poly(ethylene glycol) (PEG)-mediated fusion between pure lipid bilayers: a mechanism in common with viral fusion and secretory vesicle release? Mol Membr Biol. 1999;16(4):279-96. PubMed PMID: 10766128. Epub 2000/04/15. eng.
87. Lee SJ, Schlesinger PH, Wickline SA, Lanza GM, Baker NA. Simulation of fusion-mediated nanoemulsion interactions with model lipid bilayers. Soft Matter. 2012;8(26):3024-35. PubMed PMID: 22712024. Pubmed Central PMCID: PMC3375911. Epub 2012/06/20. Eng.
88. Bloom M, Evans E, Mouritsen OG. Physical properties of the fluid lipid-bilayer component of cell membranes: a perspective. Q Rev Biophys. 1991;24(3):293-397. PubMed PMID: 1749824. Epub 1991/08/01. eng.
89. Virden JW, Berg JC. NACL-induced aggregation of dipalmitoylphosphatidylglycerol small unilamellar vesicles with varying amounts of incorporated cholesterol. Langmuir. 1992;8(6):1532-7. PubMed PMID: WOS:A1992JA58300007.
90. Mayer LD, Bally MB, Hope MJ, Cullis PR. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim Biophys Acta. 1985;816(2):294-302. PubMed PMID: 3839135. Epub 1985/06/27. eng.
91. Mayhew E, Rustum YM, Szoka F, Papahadjopoulos D. Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes. Cancer Treat Rep. 1979;63(11-12):1923-8. PubMed PMID: 526925. Epub 1979/11/01. eng.
92. Dos Santos N, Mayer LD, Abraham SA, Gallagher RC, Cox KA, Tardi PG, et al. Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes. Biochim Biophys Acta. 2002;1561:188-201. Netherlands.
93. Taira MC, Chiaramoni NS, Pecuch KM, Alonso-Romanowski S. Stability of liposomal formulations in physiological conditions for oral drug delivery. Drug Deliv. 2004;11:123-8. England.
94. Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12:1068-75. England.
95. Castelli F, Puglia C, Sarpietro MG, Rizza L, Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm. 2005;304:231-8. Netherlands.
96. Simon SL. Temperature-modulated differential scanning calorimetry: theory and application. Thermochim Acta. 2001;374(1):55-71. PubMed PMID: WOS:000171624700008.
97. Bunjes H, Unruh T. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev. 2007;59(6):379-402. PubMed PMID: WOS:000249543300003.
98. Aburahma MH, Abdelbary GA. Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. International Journal of Pharmaceutics. Netherlands: 2011 Elsevier B.V; 2012. 422:139-50.
99. Hancock BC, Morris KR, Wildfong PL. A priori performance predictions in the pharmaceutical sciences. Int J Pharm. 2011;418:149-50. Netherlands.
100. Jepson MA, Clark MA, Hirst BH. M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery. Adv Drug Deliv Rev. 2004;56:511-25. Netherlands.
101. Zhang N, Ping QN, Huang GH, Xu WF. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm. 2005;294:247-59. Netherlands.
102. Wagner S, Lynch NJ, Walter W, Schwaeble WJ, Loos M. Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. J Immunol. 2003;170(3):1462-5. PubMed PMID: 12538708. Epub 2003/01/23. eng.
103. Ermak TH, Giannasca PJ. Microparticle targeting to M cells. Adv Drug Deliv Rev. 1998;34:261-83.
104. Palumbo RN, Wang C. Bacterial invasin: structure, function, and implication for targeted oral gene delivery. Curr Drug Deliv. 2006;3(1):47-53. PubMed PMID: 16472093. Epub 2006/02/14. eng.
105. Hoffmann PR, Jourdan-Le Saux C, Hoffmann FW, Chang PS, Bollt O, He Q, et al. A role for dietary selenium and selenoproteins in allergic airway inflammation. J Immunol. 2007;179:3258-67. United States.